Core Viewpoint - The company has announced significant governance changes, including the cancellation of the supervisory board and amendments to its articles of association, in compliance with new regulations effective from July 1, 2024 [39]. Financial Data - The third-quarter financial report for 2025 has been approved, although it has not been audited [3][10]. - The report includes key financial data and indicators, but specific figures are not detailed in the provided documents [3]. Governance Changes - The company will no longer have a supervisory board; its functions will be transferred to the audit committee of the board of directors [39]. - Amendments to the articles of association will reflect this change, removing references to the supervisory board and updating governance structures accordingly [39][40]. - The proposed changes will be submitted for approval at the second extraordinary general meeting of shareholders in 2025 [14][22]. Meeting Details - The third board meeting was held on October 27, 2025, with all directors present, confirming the legality and validity of the meeting [9][12]. - The supervisory board also convened on the same day, with all members present, to review the same reports and proposals [28][30].

Core Insights - The company reported a revenue of 2.718 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 33.18% [1] - The net profit attributable to the parent company was 203 million yuan, showing a year-on-year decline of 30.94% [1] - The non-recurring net profit was 194 million yuan, which also reflects a year-on-year decrease of 32.55% [1] - The basic earnings per share stood at 0.95 yuan [1]

Core Viewpoint - Haoyue Care (605009.SH) reported a significant increase in total operating revenue for the first three quarters of 2025, but a notable decline in net profit attributable to shareholders [1] Financial Performance - Total operating revenue reached 2.718 billion yuan, reflecting a year-on-year growth of 33.18% [1] - Net profit attributable to shareholders was 203 million yuan, showing a year-on-year decrease of 30.94% [1] - Basic earnings per share stood at 0.95 yuan [1]

证券代码：605009 证券简称：豪悦护理 公告编号：2025-052 杭州豪悦护理用品股份有限公司 关于取消监事会并修订《公司章程》及相关制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 杭州豪悦护理用品股份有限公司（以下简称"公司"）于2025年10月27日召开第 三届董事会第十七次会议、第三届监事会第十三次会议，审议通过《关于取消监事 会并修订<公司章程>的议案》和《关于修订公司相关制度的议案》，现将有关情况 公告如下： 一、取消监事会情况 根据2024年7月1日起实施的新《公司法》及中国证监会发布的《关于新<公司 法>配套制度规则实施相关过渡期安排》《上市公司章程指引（2025年修订）》《上 市公司股东会规则（2025年修订）》以及《上市公司信息披露管理办法（2025年修 订）》等相关法律法规的规定，并结合公司实际情况，公司将不再设置监事会， 监事会的职权由公司董事会审计委员会行使，公司《监事会议事规则》等监事会 相关制度相应废止，并对《公司章程》及相关制度同步进行修订。 在公司股东大会审议通过取消监事会事项 ...

Group 1 - The core viewpoint of the article highlights the financial performance of Haoyue Nursing in Q3 2025, showing a revenue increase but a significant decline in net profit [1] Group 2 - Haoyue Nursing reported a revenue of approximately 2.718 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 33.18% [1] - The net profit attributable to shareholders of the listed company was approximately 203 million yuan, reflecting a year-on-year decrease of 30.94% [1] - As of the report date, Haoyue Nursing's market capitalization stood at 7.2 billion yuan [2]

证券代码：605009 证券简称：豪悦护理 公告编号：2025-055 杭州豪悦护理用品股份有限公司 关于召开2025年第二次临时股东大会的通知 召开的日期时间：2025 年 11 月 12 日 14 点 30 分 召开地点：浙江省杭州市临平区东湖街道临平经济技术开发区红丰路 655 号 股东大会召开日期：2025年11月12日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (四)现场会议召开的日期、时间和地点 (一)股东大会类型和届次 2025年第二次临时股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 11 月 12 日 至2025 年 11 月 12 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时 ...

证券代码：605009 证券简称：豪悦护理 公告编号：2025-051 杭州豪悦护理用品股份有限公司 第三届监事会第十三次会议决议公告 二、监事会会议审议情况： 1、审议并通过《2025年第三季度报告》 具体内容详见公司披露于上海证券交易所网站（www.sse.com.cn）的《2025年第三 季度报告》。 表决结果：3票同意，0票反对，0票弃权。 2、审议并通过《关于取消监事会并修订<公司章程>的议案》 根据2024年7月1日起实施的新《公司法》及中国证监会发布的《关于新< 公司法>配套制度规则实施相关过渡期安排》《上市公司章程指引（2025年修订） 》《上市公司股东会规则（2025年修订）》以及《上市公司信息披露管理办 法（2025年修订）》等相关法律法规的规定，并结合公司实际情况，公司将 不再设置监事会，监事会的职权由公司董事会审计委员会行使，公司《监事 会议事规则》等监事会相关制度相应废止，并对《公司章程》进行修订。 本议案尚需提交公司2025年第二次临时股东大会审议。 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 ...

证券代码：605009 证券简称：豪悦护理 公告编号：2025-050 杭州豪悦护理用品股份有限公司 第三届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 杭州豪悦护理用品股份有限公司（以下简称"公司"）第三届董事会第十七次 会议于2025年10月27日在公司会议室以现场结合通讯的方式召开。会议通知已于 2025年10月22日通过邮件方式送达全体董事。本次会议由公司董事长李志彪先生召 集并主持，应出席会议董事7名，实际出席会议董事7名。本次会议的通知、召开 及表决程序符合《中华人民共和国公司法》等法律法规及《公司章程》的规定， 会议决议合法、有效。公司监事、高级管理人员列席了本次会议。 二、董事会会议审议情况： 1、审议并通过《2025年第三季度报告》 本议案尚需提交公司2025年第二次临时股东大会审议。 表决结果：7票同意，0票反对，0票弃权。 3、审议并通过《关于修订公司相关制度的议案》 为了进一步完善公司治理结构，促进公司规范运作，与修订后的《公司章程》规 定保持一致， ...

Financial Performance - The company's operating revenue for Q3 2025 reached ¥958,485,931.39, representing a year-on-year increase of 31.65%[4] - The total profit for the period was ¥63,384,826.27, showing a significant decrease of 43.96% compared to the same period last year[4] - The net profit attributable to shareholders was ¥54,876,612.91, down 45.36% year-on-year[4] - The basic earnings per share for the quarter was ¥0.35, reflecting a decline of 25.10% compared to the previous year[5] - Net profit for the first three quarters of 2025 was CNY 203.36 million, a decrease of 30.93% compared to CNY 294.45 million in the same period of 2024[20] - Operating profit for the first three quarters of 2025 was CNY 231.21 million, down from CNY 337.03 million in the previous year, representing a decline of 31.39%[20] - The company reported a total comprehensive income of CNY 213.33 million for the first three quarters of 2025, compared to CNY 277.56 million in 2024, reflecting a decrease of 23.19%[21] - Basic and diluted earnings per share for the first three quarters of 2025 were both CNY 0.95, down from CNY 1.35 in the same period of 2024, a decline of 29.63%[21] Assets and Liabilities - The total assets increased by 7.69% to ¥5,224,819,236.02 compared to the end of the previous year[5] - Total assets as of September 30, 2025, amounted to ¥5,224,819,236.02, up from ¥4,851,759,098.61 at the end of 2024, representing a growth of approximately 7.7%[17] - Total liabilities increased to ¥1,838,975,764.01 from ¥1,550,622,539.98, indicating a rise of about 18.6%[16] - The company's equity attributable to shareholders reached ¥3,385,843,472.01, compared to ¥3,301,136,558.63 in the previous year, reflecting an increase of approximately 2.5%[17] Cash Flow - Cash flow from operating activities for the year-to-date was ¥65,676,479.00, a decrease of 73.76% compared to the previous year[4] - Cash flow from operating activities for the first three quarters of 2025 was CNY 65.68 million, a significant decrease of 73.74% compared to CNY 250.32 million in 2024[23] - Cash and cash equivalents as of September 30, 2025, were ¥455,184,139.44, a decrease from ¥1,382,527,655.60 at the end of 2024[15] - Cash and cash equivalents at the end of the third quarter of 2025 were CNY 455.18 million, a decrease of 68.32% from CNY 1.44 billion at the end of the third quarter of 2024[23] - The company incurred a net cash outflow from investing activities of CNY 955.07 million in the first three quarters of 2025, compared to a net outflow of CNY 908.53 million in 2024[23] Revenue and Costs - Total operating revenue for the first three quarters of 2025 reached ¥2,718,448,586.25, a significant increase from ¥2,041,141,698.02 in the same period of 2024, representing a growth of approximately 33.2%[19] - Total operating costs for the first three quarters of 2025 were ¥2,503,834,445.03, compared to ¥1,723,158,469.40 in 2024, indicating an increase of about 45.2%[19] - The gross profit margin for the first three quarters of 2025 was approximately 7.9%, down from the previous year's margin due to rising costs[19] - Total revenue from sales of goods and services for the first three quarters of 2025 reached CNY 2.72 billion, an increase of 35.66% from CNY 2.01 billion in the same period of 2024[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 23,367[12] - Major shareholder Li Zhibiao holds 34.89% of the shares, followed by Zhu Weili with 22.08%[12] Research and Development - Research and development expenses increased by 30.44 million, reflecting higher investment in R&D[10] - Research and development expenses for the first three quarters of 2025 were ¥96,806,336.22, up from ¥74,213,145.26 in 2024, indicating a growth of about 30.5%[19] Other Financial Metrics - The weighted average return on equity decreased to 1.65%, down 46.69% from the previous year[5] - The weighted average return on net assets for the current reporting period was -46.69%[10] - The company reported non-recurring gains of ¥6,480,570.08 for the period, after accounting for tax effects[7] - Total assets impairment loss amounted to 1,386.72 million, mainly due to equipment impairment provisions[10] - The company raised CNY 310 million in borrowings during the first three quarters of 2025, compared to CNY 300 million in the same period of 2024, indicating a slight increase of 3.33%[23] - Other comprehensive income after tax for the first three quarters of 2025 was CNY 9.97 million, a recovery from a loss of CNY 16.89 million in the same period of 2024[20]

证券代码：605009 证券简称：豪悦护理 公告编号：2025-054 杭州豪悦护理用品股份有限公司 关于注销部分回购股份的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 杭州豪悦护理用品股份有限公司(以下简称"公司")于 2025 年 10 月 27 日 召开第三届董事会第十七次会议，审议通过了《关于注销部分回购股份的议案》， 同意公司注销回购股份 80,507 股，该事项尚需提交股东大会审议。现将相关情 况公告如下： 一、股份回购情况概述 1、公司分别于 2022 年 4 月 25 日召开第二届董事会第十三次会议，于 2022 年 5 月 16 日召开 2021 年年度股东大会，均审议通过了《杭州豪悦护理用品股份 有限公司关于以集中竞价交易方式回购公司股份方案的议案》（以下简称《回购 方案》），同意公司通过自有资金以集中竞价交易方式回购公司股份，回购资金总 额不低于人民币 3,000 万元（含），不超过人民币 6,000 万元（含），回购股份价 格不超过人民币 60.00 元/股，回购期限自公司股东大会审议通过回购股 ...